Purpose: To provide a clinical framework for the diagnosis and treatment of interstitial
cystitis/bladder pain syndrome. Materials and Methods: A systematic review of the literature …

Background: Dimethyl sulfoxide (DMSO) has been used for medical treatment and as a
pharmacological agent in humans since the 1960s. Today, DMSO is used mostly for …

Purpose: This guideline provides direction to clinicians and patients regarding how to
recognize interstitial cystitis/bladder pain syndrome (IC/BPS), conduct a valid diagnostic …

Aims The purpose of this review is to update the current understanding of dimethyl sulfoxide
(DMSO) and its role in the treatment of interstitial cystitis (IC). Methods A systematic review …

Introduction: Over the last 100 years, the terminology and diagnosis criteria for interstitial
cystitis have evolved. Many therapeutic options have changed, but others have endured …

For the first time, the collective data on the biological, chemical, and medical actions of
DMSO are presented and analyzed from the published scientific literature. This book …

Bladder pain syndrome/interstitial cystitis (BPS/IC) is a chronic disease characterised by
persistent irritating micturition symptoms and pain. The objective was to compare the clinical …

Bladder pain syndrome/interstitial cystitis (BPS/IC) is a disabling chronic condition that
affects up to 7% of women in the USA. In men, BPS/IC seems to be less common, but might …

Bladder pain syndrome (BPS)/interstitial cystitis (IC) is a chronic symptom complex that may
cause bothersome storage symptoms and pain or discomfort of the bladder, adversely …

Introduction and hypothesis For decades, intravesical dimethyl sulfoxide (DMSO) cocktail
therapy has been used for the treatment of interstitial cystitis/bladder pain syndrome …